Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the "analytical quality by design" approach
| Permalink: | http://skupni.nsk.hr/Record/nsk.NSK01001155984/Similar |
|---|---|
| Matična publikacija: |
Acta pharmaceutica (Zagreb) 70 (2020), 1 ; str. 17-33 |
| Glavni autori: | Saha, Chandni (Author), Gupta, N. Vishal, Chandan, R. S. |
| Vrsta građe: | Članak |
| Jezik: | eng |
| Predmet: | |
| Online pristup: |
Elektronička verzija članka |
APA stil citiranja
Saha, C. (2020). Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the "analytical quality by design" approach: Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the "analytical quality by design" approach. Acta pharmaceutica (Zagreb).
Chicago stil citiranjaSaha, Chandni. "Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the "analytical quality by design" approach: Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the "analytical quality by design" approach." 2020.
MLA stil citiranjaSaha, Chandni. "Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the "analytical quality by design" approach: Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the "analytical quality by design" approach." 2020.